Jennifer Desimone, MD
Dermatology · Fairfax, VANPI 1861659799
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (54.1%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Helsinn Therapeutics (U.S.), Inc. at 31.8% of the total. Reporting peaked in 2019 at $40,151 and has fallen 91.1% since, to $3,588 in 2025. Among dermatology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 86 payments — averaging $954.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Helsinn Therapeutics (U.S.), Inc.$26K
- Sanofi$20K
- Regeneron$13K
- Kyowa Kirin, Inc.$12K
- Regeneron Healthcare Solutions, Inc.$11K
- AbbVie$124
- plus $206 from 3 others
Across 70 payments — averaging $31,660 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$1.8M
- Regeneron$199K
- Seagen Inc.$161K
- Kyowa Kirin Services Ltd$47K
What the payments were for
- Consulting fees$44,44754%
- Speaking & faculty fees$29,79736%
- Travel & lodging$6,4708%
- Food & beverage$1,2912%
- Education$770%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Helsinn Therapeutics (U.S.), Inc. | 25 | $26,114 |
| Sanofi | 21 | $19,687 |
| Regeneron | 17 | $12,899 |
| Kyowa Kirin, Inc. | 12 | $11,912 |
| Regeneron Healthcare Solutions, Inc. | 6 | $11,139 |
| AbbVie | 1 | $124 |
| Bristol Myers Squibb | 1 | $110 |
| Krystal Biotech Inc | 1 | $51 |
| Novartis | 2 | $45 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$82,082 in reported general payments places this provider in the 95th percentile of 396 dermatology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bexarotene | 30 | $463,678 |
| ValchlorMechlorethamine Hcl | 39 | $272,975 |
| Acitretin | 32 | $9,969 |
| Clobetasol Propionate | 22 | $1,243 |
| Fluocinonide | 21 | $1,020 |
| Fluorouracil | 15 | $1,007 |
| Triamcinolone Acetonide | 37 | $412 |
| Imiquimod | 18 | $353 |
| Ketoconazole | 13 | $169 |
| ValacyclovirValacyclovir Hcl | 11 | $137 |
| Levothyroxine Sodium | 11 | $102 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Fairfax
- Saurabh SinghFairfax$1.7M
- Hema SundaramFairfax$181K
- Michele MagninoFairfax$33K
- Naiem IssaVienna$2M
- Diego DasilvaVirginia Beach$1.1M
- Vishal PatelLeesburg$719K
- Cyndi Torosky TommasoVirginia Beach$717K
- Daniel HurdBlacksburg$545K
- Jonathan SchreiberNorfolk$330K
- Robert BaerSuffolk$303K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.